Literature DB >> 22210045

Look who's talking: deregulated signaling in colorectal cancer.

Mohammed Abba1, Stephanie Laufs, Monireh Aghajany, Bernhard Korn, Axel Benner, Heike Allgayer.   

Abstract

BACKGROUND: The phenotypic expression of any given heterogeneous tissue type is the composite of interactions between individual cell types governed principally by inherent, cell-specific molecular mechanisms.
MATERIALS AND METHODS: Using a combination of laser-capture microdissection, oligonucleotide microarrays, bioinformatic and statistical tools, we analyzed colorectal cancer tissues in order to spot the significant pathways that were differentially deregulated between the epithelial and stromal compartments and compared these alongside the ones of whole tissue dissection.
RESULTS: The stromal pathway profiles were very similar to the ones of whole tissue, in contrast to the epithelial input, with stroma emerging as the major determinant of the cancer phenotype. Differentially expressed genes in the epithelial compartment correlated significantly with the carbohydrate antigen 19-9 tumor marker.
CONCLUSION: The accurate interpretation of data arising from the analysis of heterogeneous tissue structures lends itself to inherent biases of its constitutive components with each component presenting explorable analytical advantages.

Entities:  

Mesh:

Year:  2012        PMID: 22210045

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  6 in total

1.  Comparison of genetic and epigenetic alterations of primary tumors and matched plasma samples in patients with colorectal cancer.

Authors:  Elisa Danese; Anna Maria Minicozzi; Marco Benati; Martina Montagnana; Elisa Paviati; Gian Luca Salvagno; Gabriel Lima-Oliveira; Milena Gusella; Felice Pasini; Giuseppe Lippi; Gian Cesare Guidi
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

2.  Circumvent the uncertainty in the applications of transcriptional signatures to tumor tissues sampled from different tumor sites.

Authors:  Jun Cheng; You Guo; Qiao Gao; Hongdong Li; Haidan Yan; Mengyao Li; Hao Cai; Weicheng Zheng; Xiangyu Li; Weizhong Jiang; Zheng Guo
Journal:  Oncotarget       Date:  2017-05-02

3.  Robust transcriptional tumor signatures applicable to both formalin-fixed paraffin-embedded and fresh-frozen samples.

Authors:  Rou Chen; Qingzhou Guan; Jun Cheng; Jun He; Huaping Liu; Hao Cai; Guini Hong; Jiahui Zhang; Na Li; Lu Ao; Zheng Guo
Journal:  Oncotarget       Date:  2017-01-24

4.  Identification of Transcriptional Markers and microRNA-mRNA Regulatory Networks in Colon Cancer by Integrative Analysis of mRNA and microRNA Expression Profiles in Colon Tumor Stroma.

Authors:  Md Nazim Uddin; Mengyuan Li; Xiaosheng Wang
Journal:  Cells       Date:  2019-09-08       Impact factor: 6.600

5.  Identification of Transcriptional Signatures of Colon Tumor Stroma by a Meta-Analysis.

Authors:  Md Nazim Uddin; Mengyuan Li; Xiaosheng Wang
Journal:  J Oncol       Date:  2019-05-02       Impact factor: 4.375

6.  SELENBP1 inhibits progression of colorectal cancer by suppressing epithelial-mesenchymal transition.

Authors:  Xiaotian Zhang; Runqi Hong; Lanxin Bei; Zhiqing Hu; Ximin Yang; Tao Song; Liang Chen; He Meng; Gengming Niu; Chongwei Ke
Journal:  Open Med (Wars)       Date:  2022-09-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.